Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study.
Within the conventional system of medication in India Ashwagandha powder and Sidh Makardhwaj have been used for the therapy of rheumatoid arthritis. Nonetheless, security and efficacy of this therapy haven’t been evaluated. Due to this fact, the current examine was carried out to guage the efficacy and security of Ayurvedic therapy (Ashwagandha powder and Sidh Makardhwaj) in sufferers with rheumatoid arthritis.
METHODS
100 and twenty 5 sufferers with joint ache have been screened at an Ayurvedic hospital in New Delhi, India. Eighty six sufferers happy inclusion standards and have been included within the examine. Detailed medical historical past and bodily examination have been recorded. Sufferers took 5g of Ashwagandha powder twice a day for 3 weeks with lukewarm water or milk. Sidh Makardhwaj (100 mg) with honey was administered day by day for the following 4 weeks. The observe up of sufferers was carried out each two weeks. The first efficacy finish level was primarily based on American Faculty of Rheumatology (ACR) 20 response. Secondary finish factors have been ACR50, ACR70 responses, change from baseline in illness exercise rating (DAS) 28 rating and ACR parameters. Security assessments have been hepatic perform [alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), bilirubin and ß2 microglobulin], renal perform (urea and creatinine and NGAL) exams and urine mercury degree.
RESULTS
The examine was accomplished by 90.7 per cent (78/86) sufferers. Sufferers with average and excessive illness exercise have been 57.7 per cent (45/78) and 42.three per cent (33/78), respectively. All sufferers have been examined optimistic for rheumatoid issue and elevated ESR degree. Ashwagandha and Sidh Makardhwaj therapy decreased RA issue. A major change in post-treatment scores of tender joint counts, swollen joint counts, doctor international evaluation rating, affected person international evaluation rating, ache evaluation rating, affected person self assessed incapacity index rating and ESR degree have been noticed as in comparison with baseline scores. ACR20 response was noticed in 56.four per cent (44/78) sufferers (American Faculty of Rheumatology standards) and average response in 39.74 per cent (31/78) sufferers [European League Against Rheumatism (EULAR) criteria]. Ayurvedic therapy for seven weeks in rheumatoid arthritis sufferers confirmed regular kidney and liver perform exams. Nonetheless, elevated urinary mercury ranges have been was noticed after therapy.
CONCLUSIONS
The findings of the current examine counsel that this Ayurvedic therapy (Ashwagandha powder and Sidh Makardhwaj) has a possible for use for the therapy of rheumatoid arthritis. Nonetheless, resulting from small pattern measurement, quick length, non randomization and lack of a management group as examine limitations, additional research should be achieved to verify these findings.
Ayurpharmacoepidemiology en Path to Safeguarding Security and Efficacy of Ayurvedic Medication in International Outlook.
Ayurpharmacoepidemiology is a brand new area developed by synergy of the fields of scientific pharmacology, epidemiology, and ayurveda. It should use the consequences of ayurvedic medicinal merchandise on giant populations to explain and analyze the practices, consider the protection and efficacy, and perform medicoeconomic evaluations. Good pharmacoepidemiology practices in ayurveda is projected to help with problems with ayurpharmacoepidemiologic analysis.
The embraced good pharmacoepidemiology practices guideline on this viewpoint will have the ability to present invaluable proof in regards to the well being results of ayurvedic herbs/medication and think about totally different fields like pharmacovigilance, pharmacoeconomics, and drug discovery with ayurvedic reverse pharmacology strategy, additionally cross out vital knowledge for additional primary sciences examine in ayurveda biology, ayurgenomics, ayurnutrigenomics, and programs biology. A number of unanswered questions on ayurvedic drug use and knowledgeable interventions or insurance policies that may be addressed by informatics database, which is able to ultimately exhibit the credibility and rationality of ayurceuticals sooner or later.
Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study.
[Computer evaluation of hidden potential of phytochemicals of medicinal plants of the traditional Indian ayurvedic medicine].
Applicability of our laptop applications PASS and PharmaExpert to prediction of organic exercise spectra of quite complicated and structurally numerous phytocomponents of medicinal crops, each individually and in mixtures has been evaluated. The online-resource on phytochemicals of 50 medicinal crops utilized in Ayurveda was created for the examine of hidden therapeutic potential of Conventional Indian Drugs (TIM) . It incorporates info on 50 medicinal crops, their utilizing in TIM and their pharmacology actions, additionally as 1906 phytocomponents.
PASS coaching set was up to date by addition of details about 946 pure compounds; then the coaching process and validation have been carried out, to estimate the standard of PASS prediction. It was proven that the distinction between the typical accuracy of prediction obtained in leave-5%-out cross-validation (94,467%) and in leave-one-out cross-validation (94,605%) may be very small. These outcomes confirmed excessive predictive capability of this system. Outcomes of organic exercise spectra prediction for all phytocomponents included in our database are in good correspondence with the experimental knowledge. Extra sorts of organic exercise predicted with excessive chance present the details about most promising instructions of additional research.
Should the Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Canine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Canine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Human Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Human Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.
Should the Rat Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Should the Rat Leukemia Inhibitory Factor (LIF) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Description: The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse LIF in samples from serum, plasma, tissue homogenates and other biological fluids.
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications:
Immunogen information: Synthesized peptide derived from the C-terminal region of human LIF
Applications tips:
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF
Immunogen information: Synthesized peptide derived from the C-terminal region of human LIF
Applications tips:
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF
Immunogen information: Synthesized peptide derived from the C-terminal region of human LIF
Applications tips:
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF (Internal). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF (Center). This antibody is tested and proven to work in the following applications:
Description: LIF is a pleiotrophic factor produced by multiple cell types including T cells, myelomoncytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant human LIF is a 19.6 kDa protein containing 180 amino acids residues including three disulfide bonds.
The evaluation of prediction outcomes of units of phytocomponents in every of 50 medicinal crops was made by PharmaExpert software program. Based mostly on this evaluation, we discovered that the mix of phytocomponents from Passiflora incarnata might exhibit nootropic, anticonvulsant and antidepressant results. Experiments carried out in mice fashions confirmed the expected results of Passiflora incarnata extracts.
by 
 ELISA Kit)
Mouse Leukemia Inhibitory Factor (LIF) ELISA Kit 
anti-LIF  ELISA Kit)
Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Canine Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Human Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit  ELISA Kit)
Rat Leukemia Inhibitory Factor (LIF) ELISA Kit 
anti- LIF antibody 
Anti-LIF Antibody 
Anti-LIF antibody 
Rabbit Polyclonal antibody Anti-CRBN 
LIF, Mouse 
LIF, mouse  antibody)
Anti-LIF (aa28-39) antibody 
Mouse LIF ELISA Kit 
Mouse LIF shRNA Plasmid 
Recombinant Mouse LIF Protein 
Polyclonal Goat anti-GST α-form 
Polyclonal Goat anti-GST μ-form 
Polyclonal Goat anti-GST p-form 
rHu LIF 
LIF, Human 
LIF siRNA 
LIF antibody 
LIF Antibody 
LIF protein 
LIF, human 
ELISA kit for Mouse LIF 
Mouse LIF PicoKine ELISA Kit 
Human CellExp? LIF, mouse recombinant , mouse)
Leukemia Inhibitory Factor (LIF), mouse 
LIF, Mouse Recombinant , 1MIU/ml 
LIF, Mouse Recombinant , 10MIU/ml  (pORF))
Lif ORF Vector (Mouse) (pORF)  (OKEH04045))
LIF ELISA Kit (Mouse) (OKEH04045)  (OKBB00760))
LIF ELISA Kit (Mouse) (OKBB00760) 
Polyclonal LIF Antibody 
LIF Conjugated Antibody 
LIF Polyclonal Antibody 
LIF Blocking Peptide 
LIF Rabbit pAb 
LIF, human recombinant 
LIF, murine recombinant 
Recombinant Mouse Leukemia Inhibitory Factor/lIF  Protein)
Mouse Leukemia Inhibitory Factor (LIF) Protein )
Lif sgRNA CRISPR Lentivector set (Mouse) )
LIF, Leukemia inhibitory factor, murine (mouse) )
Polyclonal LIF Antibody (Internal) )
Polyclonal LIF Antibody (Center) 
Human LIF ELISA Kit 
Goat LIF ELISA Kit 
LIF/Leukemia inhibitory factor 
Bovine LIF ELISA Kit 
Chicken LIF ELISA Kit 
Canine LIF ELISA Kit 
Anserini LIF ELISA Kit 
LIF ELISA KIT|Human 
Porcine LIF ELISA Kit 
Rat LIF ELISA Kit 
Rabbit LIF ELISA Kit 
Sheep LIF ELISA Kit 
Monkey LIF ELISA Kit 
Human LIF ELISA kit 
Human LIF shRNA Plasmid 
Recombinant Human LIF Protein  Protein (Active))
Mouse Leukemia Inhibitory Factor (LIF) Protein (Active) 
Mouse Lif/ Leukemia inhibitory factor ELISA Kit ELISA Kit )
Mouse Leukemia inhibitory factor(LIF)ELISA Kit  ELISA Kit)
Mouse Lif(Leukemia inhibitory factor) ELISA Kit 
